Clinical Focus

Previous Articles     Next Articles

Advances in anticoagulant therapy after acute coronary syndrome

  

  1. Department of Cardiology,  the Second Hospital of Hebei Medical University,  Shijiazhuang 050000,  China
  • Online:2018-09-05 Published:2018-09-26
  • Contact: Corresponding author: Wang Mei, Email: wangmei86632@sina.com

Abstract: Vascular endothelial damage caused by erosion or rupture of coronary atherosclerotic plaque is the pathophysiological basis of thrombosis in coronary artery lesions. The onset of acute coronary syndrome(ACS)   is often accompanied by changes in electrocardiogram,  increased markers of myocardial injury and the appearance of symptoms of angina pectoris. Antiplatelet and anticoagulant therapy is the key to the treatment of ACS. The effective use of antiplatelet and anticoagulant drugs can reduce the occurrence of ischemic events such as myocardial infarction,  thrombosis in stent and a reduction in mortality. This article reviews current  evidences for anticoagulants in ACS.

Key words: acute coronary syndrome, anticoagulants, ischemic, bleeding